Edition:
United States

Aviragen Therapeutics Inc (AVIR.OQ)

AVIR.OQ on NASDAQ Stock Exchange Capital Market

0.60USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
96,616
52-wk High
$1.48
52-wk Low
$0.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 0.10 -0.137
FY 2017 Jun '17 0.10 -0.153
Mar '17 4.90 -0.114
Dec 3.80 -0.235
Sep 0.10 -0.259
FY 2016 Jun '16 0.50 -0.181
Mar '16 5.30 -0.135
Dec 1.70 -0.168
Sep 1.70 -0.171
FY 2015 Jun '15 4.10 -0.551
Mar '15 5.90 0.034
Dec 13.90 0.185
Sep 0.70 -0.197
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 3 0.67 1.00 0.50 --
Year Ending Jun-17 3 8.43 9.80 6.20 --
Earnings (per share)
Quarter Ending Jun-17 2 -0.20 -0.17 -0.23 --
Year Ending Jun-17 2 -0.81 -0.78 -0.83 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. -- 277.36 45.22
P/E Low - Last 5 Yrs. -- 92.80 24.21
Beta -0.08 0.82 0.91
Price to Sales (TTM) 2.61 117.72 5.89
Price to Book (MRQ) 1.67 21.83 5.66
Price to Tangible Book (MRQ) 1.67 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 39.07 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago 17.11 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.01 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago 13.95 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 6.63 5.70 3.57
LT Debt to Equity (MRQ) 0.72 14.63 13.37
Total Debt to Equity (MRQ) 2.16 17.10 19.35
Interest Coverage (TTM) -286.00 -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -252.81 -- --
EBITD - 5 Yr. Avg -- -219.33 15.51
Operating Margin (TTM) -258.43 -637.28 6.68
Operating Margin - 5 Yr. Avg. -- -236.27 10.99
Pre-Tax Margin (TTM) -274.16 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -- -236.41 11.40
Net Profit Margin (TTM) -277.53 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -- -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,870,754 851,754,569
Net Income/Employee (TTM) -- -1,731,043 99,535,212
Receivable Turnover (TTM) 25.43 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.18 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.51 -9.33 11.32
Return on Assets - 5 Yr. Avg. -- 0.11 12.28
Return on Investment (TTM) -58.95 -11.61 14.44
Return on Investment - 5 Yr. Avg. -- 3.32 16.08
Return on Equity (TTM) -97.82 -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -4.30 -49.40 --
EPS (TTM) % -15.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aviragen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.25%
# of Holders: 40
Total Shares Held: 15,556,536
3 Mo. Net Change: 895,892
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 11
# Reduced Positions: 8
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.